- Home
- SEER vs ORMP Comparison
SEER vs ORMP Comparison
Compare SEER & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEER
- ORMP
- Stock Information
- Founded
- SEER 2017
- ORMP 2002
- Country
- SEER United States
- ORMP United States
- Employees
- SEER N/A
- ORMP N/A
- Industry
- SEER Medicinal Chemicals and Botanical Products
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- SEER Health Care
- ORMP Health Care
- Exchange
- SEER Nasdaq
- ORMP Nasdaq
- Market Cap
- SEER 113.8M
- ORMP 104.6M
- IPO Year
- SEER 2020
- ORMP N/A
- Fundamental
- Price
- SEER $2.25
- ORMP $2.39
- Analyst Decision
- SEER
- ORMP
- Analyst Count
- SEER 0
- ORMP 0
- Target Price
- SEER N/A
- ORMP N/A
- AVG Volume (30 Days)
- SEER 133.0K
- ORMP 122.6K
- Earning Date
- SEER 11-05-2025
- ORMP 11-06-2025
- Dividend Yield
- SEER N/A
- ORMP N/A
- EPS Growth
- SEER N/A
- ORMP N/A
- EPS
- SEER N/A
- ORMP N/A
- Revenue
- SEER $16,288,000.00
- ORMP $2,000,000.00
- Revenue This Year
- SEER $27.77
- ORMP N/A
- Revenue Next Year
- SEER $20.28
- ORMP N/A
- P/E Ratio
- SEER N/A
- ORMP N/A
- Revenue Growth
- SEER 10.52
- ORMP N/A
- 52 Week Low
- SEER $1.62
- ORMP $1.82
- 52 Week High
- SEER $2.63
- ORMP $3.09
- Technical
- Relative Strength Index (RSI)
- SEER 56.07
- ORMP 56.54
- Support Level
- SEER $2.21
- ORMP $2.37
- Resistance Level
- SEER $2.32
- ORMP $2.57
- Average True Range (ATR)
- SEER 0.09
- ORMP 0.14
- MACD
- SEER 0.00
- ORMP -0.01
- Stochastic Oscillator
- SEER 41.05
- ORMP 44.51
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.